Drug to Cure Alcoholism Successful in Preliminary Test

French doctors said on Tuesday that a drug designed to treat nervous spasms has proved to be successful during an early test in a project to see whether it can also cure alcoholism.

Baclofen -- the lab name for a medication branded as Kemstro, Lioresal and Gablofen -- was successful in a preliminary test among a small group of alcoholics, a result that opens the way to formal clinical trials, they said.

Alcohol Abuse - Alcohol Addiction - Treatment � Rehab among Woman
Social drinking amongst women has become a fad. Stop it before it finishes you.

The history of the drug goes back 50 years. It was originally designed for epilepsy before becoming licensed to treat spasticity, but researchers are now interested in using it to ease alcoholic craving.

Interest was sparked in 2008 by a book, Le Dernier Verre (The Last Glass), by cardiologist Olivier Ameisen, who self-treated his alcoholism with high doses of baclofen.

The new test entailed enrolling 132 heavy drinkers who were given baclofen at high doses over a year.

Alcohol Use Disorder | Alcoholism
Alcohol use disorder or alcoholism is an inability to control drinking. It can cause short term and long term physical, as well as psychological effects on the patient.

Eighty percent either became abstinent or became moderate drinkers. By comparison, two drugs that are commonly used to treat alcoholics, naltrexon and acamprosate, yield a success rate of 20-25 percent.

Side effects included fatigue, drowsiness, insomnia, dizziness and digestive troubles.

Alcohol and Driving-Blood Alcohol Level-Indian Law-Walk Test and Breathalyzer
Alcohol and driving do not mix. Drunken driving is the cause of many deaths in the world.

Lead researcher Philippe Jaury of the University of Paris-Descartes said the outcome opened the door to one-year clinical trials, expected to start in May, in which 320 alcoholics would be divided into two groups.

One batch will receive baclofen, progressively building in dosage until the craving symptoms subside, while the others will receive an inactive lookalike pill, or placebo.

Alcohol - Benefits and Harms
Alcohol consumption continues to play an important role in many social and religious celebrations.However,serious risks are also associated with it!

France's health system is paying 750,000 euros ($469,000) of the 1.2-million-euro ($1.45-million) cost of the trial, and an unidentified donor is paying the rest, Jaury told AFP.

The pre-trial study is published in a specialist journal, Alcohol and Alcoholism.

Source-AFP